Monday began with grief, not medical news. Will’s mother was sitting beside her 15-year-old son’s grave when a message arrived carrying a detail she says immediately reopened questions about the final weeks of his cancer battle.

According to her account, the message concerned an idea that had once been discussed while Will was receiving DeltaRex-G during treatment at Rady Children’s Hospital. The question sounded deceptively simple: What if the drug could be delivered directly to the brain?

Will had been dealing with severe third spacing, a condition in which fluid collects outside the normal circulation. His mother says doctors believed the excess fluid may have prevented the experimental therapy from reaching his brain at an effective concentration, even while tumors elsewhere appeared to be getting smaller.

The most troubling part was what happened next.

According to the family, Dr. Gordon raised the possibility of bypassing that problem by delivering DeltaRex-G more directly toward the brain. The approach, however, was not pursued for Will, and his mother has said she believed institutional restrictions and the complexity of using an experimental treatment outside its normal administration method made the idea difficult to advance.

At the time, there was no guarantee that such an approach would have worked. Experimental cancer treatment is filled with unanswered questions, and what appears promising in theory can produce very different results in practice.

But that uncertainty is exactly what made Monday’s message so painful.

Will’s mother says she learned that another medical team later pursued a similar question with another patient, using a microdose delivered directly to the brain. According to the information she received, the approach produced a positive result.

Her reaction was immediate.

She was sitting at Will’s grave when she read it.

ONEIDEA IDEA. ONE Will’s END. fight DIDN’T It changed THE PATH FORWARD. ex-G CULAR ATION ONE QUESTION. ONECHILD’SFIGHT. ONE CHILD’S FIGHT. AFUTUREFORANOTHER. RE FOR ANOTHER. FUTURE CTLY WHENONECHILD’S WHEN ONE WHENONECH CHILD’S BATTLE BATTLELEADSTO EADS BREAKTHROUGH, OOLATE WIL Nottoolate Nottoolateforanother. Nottoo toolate late for another. KEEPSMARCHIN KEEPS KEEPSMAR MARC FORWAR’

For a parent who had spent 18 months watching her child endure cancer, the timing was almost impossible to separate from the medical details. Will had died on July 23, and now, only weeks later, she was being told that an idea once considered during his treatment had apparently been attempted elsewhere.

The obvious question followed: Could it have helped Will?

There is no responsible way to answer that with certainty.

Different patients can respond differently to the same treatment. Dose, timing, tumor biology, disease progression, organ function and dozens of other factors can determine whether an experimental intervention succeeds, fails or causes unexpected complications.

Still, medical uncertainty does not erase a grieving parent’s question.

Why was the approach not attempted for Will? What changed between the moment it was discussed in his case and the moment another team reportedly decided to try something similar? And perhaps most hauntingly, did information gained during Will’s treatment somehow influence the thinking that came afterward?

His mother does not claim to have every answer.

In fact, one of the most striking parts of her message is her refusal to force one.

She writes openly about being angry with God and rejecting the familiar phrase that “everything happens for a reason.” For her, no explanation can soften the reality of watching cancer take her son piece by piece.

Yet after the anger came another thought.

Maybe understanding why is not required before deciding what comes next.

That shift appears to be at the center of how Will’s family is beginning to interpret the message. Cancer took Will’s life, his mother writes, but it does not automatically get to take everything that came from his fight.

Will’s story reached hundreds of thousands of people. His family formed relationships with other cancer families, doctors and supporters, while his case forced difficult conversations about experimental therapies and how quickly hospitals can respond when conventional options have been exhausted.

Perhaps most importantly, Will himself had repeatedly expressed a willingness for his experience to help someone else.

His mother recalled the attitude he carried while publicly asking for help during his treatment: if it was already too late for him, maybe what happened could still help another child.

That sentence now carries a different weight.

If the account about the later patient is accurate, then the central mystery may no longer be limited to whether Will personally could have benefited from direct delivery. It may also involve whether questions raised during his treatment contributed, even indirectly, to someone else receiving an option he never had.

That possibility does not remove the pain.

It may actually make the pain sharper.

t ‘‎Will, I don’t tell you enough how proud I am of you. There are Not Nough words. I Know I’m hard you the smallest Mistakes and its not because disappointed Rm you, ゴs My way to Dush You to to be the best Please with me when Maлa gets fatient all excited and War ked yρ. 正 somethin I have Nork atience but hot day. I lack you and Charlie. you will love BIG things in life one and I will be cheering oV on ב egMauinan MoucK‎’‎

A mother can believe another patient deserved every possible chance while still wondering why her own child did not receive the same opportunity. Those two emotions are not mutually exclusive, and her post makes little attempt to pretend otherwise.

There will still be mornings when she does not want to leave bed. There will still be moments when walking past Will’s room is enough to bring the grief back without warning.

But she says she intends to keep living.

Not because she has “moved on,” but because she sees moving forward as carrying Will with her.

That distinction may become the lasting message of this chapter in his story.

Medical records, treatment decisions and future research may eventually provide clearer answers about what was possible, what was not and what doctors learned. For now, however, the most powerful question remains unresolved.

Did Will’s treatment end only with the loss of one young patient?

Or did something learned during his fight quietly travel beyond his hospital room, reach another medical team, and become part of a decision that gave someone else a chance?

For his mother, that possibility does not explain July 23.

But it may change what July 23 means.

Because if Will once believed that even a failed effort on his behalf could someday help another child, then the message received beside his grave carries one final, painful possibility:

Maybe the treatment Will never got became part of the reason somebody else did.